For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…
(MedPage Today) -- For decades, nutrition counseling in diabetes care has focused primarily on one question: What should patients eat? But a growing body of evidence suggests another question may be clinically important as well: When should patients...
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Allergist Zachary Rubin, MD, explained the "why" behind the standing ovation received by a game-changing...
(MedPage Today) -- The FDA approved intravenous cefepime and zidebactam (Zaynich) for complicated urinary tract infections (UTIs), including pyelonephritis, caused by susceptible gram-negative bacteria in adults, Wockhardt announced. The novel...
(MedPage Today) -- Using the Chart Your Fart app, Australians self-reported an average of five flatus per day, with a higher number recorded among males versus females, at 5.2 versus 4.8. (JAMA Network Open) First-in-class miR-124 enhancer obefazimod...
(MedPage Today) -- A Michigan man was arrested for allegedly pulling a gun on three hospital workers while they were on a break. (Click On Detroit) A Texas woman was arrested after allegedly assaulting emergency department staff, spitting in the...
(MedPage Today) -- The New World screwworm fly has reached south Texas, the U.S. Department of Agriculture (USDA) confirmed Wednesday, the first time in decades that the parasite with flesh-eating larvae has threatened the nation's cattle industry...
(MedPage Today) -- LONDON -- The interleukin (IL)-17A inhibitor secukinumab (Cosentyx) was clearly effective in treating polymyalgia rheumatica (PMR) in a phase III trial, researchers reported, even as they also published final data from a failed...
(MedPage Today) -- LONDON -- In yet another effort to repurpose oncology drugs for autoimmune disease, a researcher reported here that low doses of blinatumomab (Blincyto) given to patients with treatment-resistant rheumatoid arthritis (RA)...
(MedPage Today) -- CHICAGO -- A second-line triplet regimen involving the novel intravenous drug gedatolisib significantly reduced the risk of progression or death in PIK3CA-mutant hormone receptor (HR)-positive breast cancer, a phase III study...
Many adults are sharing device data with providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from health monitoring are less likely to adopt the tools, according to Rock Health.